Pejcić I - Search Results

1

Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia--the Melanoma Focus Study.

Kandolf-Sekulović L, Babović N, Jokić N, Nikolin B, Nikolić D, Janjić Z, Mijugković Z, Rajović M, Novaković M, Pejcić I, Kovaević P, Mihajlović D, Roganović T, Ferenc V, Nikolić J, Marinković M, Bizetić Z. Kandolf-Sekulović L, et al. Among authors: pejcic i. Vojnosanit Pregl. 2015 Apr;72(4):312-6. doi: 10.2298/vsp131014052k. Vojnosanit Pregl. 2015. PMID: 26040176

2

Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?

Petković I, Stojnev S, Krstić M, Pejčić I, Vrbić S. Petković I, et al. Among authors: pejcic i. Vojnosanit Pregl. 2016 Nov;73(11):1072-5. doi: 10.2298/VSP150425128P. Vojnosanit Pregl. 2016. PMID: 29341562

3

[Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].

Pejcić I, Vrbić S, Filipović S, Sćekić M, Petković I, Pejcić L, Djenić N. Pejcić I, et al. Among authors: pejcic l. Vojnosanit Pregl. 2010 Sep;67(9):723-31. doi: 10.2298/vsp1009723p. Vojnosanit Pregl. 2010. PMID: 20954411 Serbian.

4

Concurrent chemoimmunotherapy: is it still the best option for the treatment of metastatic melanoma in patients with good performance status?

Pejcic I, Vrbic S, Filipovic S, Scekic M, Petkovic I, Pejcic Lj. Pejcic I, et al. Among authors: pejcic lj. J BUON. 2010 Jul-Sep;15(3):470-4. J BUON. 2010. PMID: 20941812

5

Safety and efficacy of addition of bevacizumab to oxaliplatin-based preoperative chemotherapy in colorectal cancer with liver metastasis- a single institution experience.

Cvetanovic A, Vrbic S, Filipovic S, Pejcic I, Milenkovic D, Milenkovic N, Zivkovic N. Cvetanovic A, et al. Among authors: pejcic i. J BUON. 2013 Jul-Sep;18(3):641-6. J BUON. 2013. PMID: 24065477 Free article. Clinical Trial.

6

EBV Negative Angioimmunoblastic T-Cell Lymphoma with Sequential Development of Diffuse Large B-Cell Lymphoma in Course of Progression.

Petković I, Stojnev S, Popović A, Krstić M, Pejčić I. Petković I, et al. Among authors: pejcic i. Indian J Hematol Blood Transfus. 2021 Oct;37(4):694-696. doi: 10.1007/s12288-021-01425-w. Epub 2021 Mar 25. Indian J Hematol Blood Transfus. 2021. PMID: 34744354 Free PMC article. No abstract available.

7

Current and future anti-HER2 therapy in breast cancer.

Vrbic S, Pejcic I, Filipovic S, Kocic B, Vrbic M. Vrbic S, et al. Among authors: pejcic i. J BUON. 2013 Jan-Mar;18(1):4-16. J BUON. 2013. PMID: 23613383 Free article. Review.

8

Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.

Vrbic S, Pejcic I, Vrbic M, Filipovic S. Vrbic S, et al. Among authors: pejcic i. J BUON. 2009 Jan-Mar;14(1):41-4. J BUON. 2009. PMID: 19373945

9

Chemotherapy in carcinomas of unknown primary site.

Pejcić I, Vrbić S, Filipović S, Radić S, Pejcić Lj. Pejcić I, et al. Among authors: pejcic lj. J BUON. 2004 Jan-Mar;9(1):27-31. J BUON. 2004. PMID: 17385824

10

Clinical benefit of cetuximab and prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer: a single institution analysis.

Cvetanovic A, Vrbic S, Filipovic S, Pejcic I, Milenkovic D, Zivkovic N, Kostic M, Petkovic I. Cvetanovic A, et al. Among authors: pejcic i. J BUON. 2014 Jan-Mar;19(1):83-90. J BUON. 2014. PMID: 24659647 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters